Bank of New York Mellon Corp Sells 4,213 Shares of Fresenius Medical Care AG & Co. (NYSE:FMS)

Share on StockTwits

Bank of New York Mellon Corp lowered its stake in shares of Fresenius Medical Care AG & Co. (NYSE:FMS) by 30.2% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 9,747 shares of the company’s stock after selling 4,213 shares during the quarter. Bank of New York Mellon Corp’s holdings in Fresenius Medical Care AG & Co. were worth $382,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently modified their holdings of FMS. NEXT Financial Group Inc bought a new stake in Fresenius Medical Care AG & Co. during the second quarter valued at about $29,000. Lindbrook Capital LLC boosted its position in Fresenius Medical Care AG & Co. by 163.0% during the second quarter. Lindbrook Capital LLC now owns 781 shares of the company’s stock valued at $30,000 after purchasing an additional 484 shares in the last quarter. Ashburton Jersey Ltd bought a new stake in Fresenius Medical Care AG & Co. during the second quarter valued at about $39,000. Rehmann Capital Advisory Group boosted its position in Fresenius Medical Care AG & Co. by 46.7% during the first quarter. Rehmann Capital Advisory Group now owns 2,565 shares of the company’s stock valued at $104,000 after purchasing an additional 817 shares in the last quarter. Finally, Bailard Inc. acquired a new stake in Fresenius Medical Care AG & Co. in the second quarter worth about $237,000. 1.47% of the stock is currently owned by institutional investors.

Shares of NYSE FMS opened at $32.92 on Tuesday. The company has a debt-to-equity ratio of 0.77, a quick ratio of 0.76 and a current ratio of 0.99. The company has a market cap of $19.74 billion, a PE ratio of 14.50, a P/E/G ratio of 2.34 and a beta of 1.46. The business has a 50-day simple moving average of $33.69 and a two-hundred day simple moving average of $37.21. Fresenius Medical Care AG & Co. has a fifty-two week low of $30.99 and a fifty-two week high of $49.93.

Fresenius Medical Care AG & Co. (NYSE:FMS) last issued its quarterly earnings results on Tuesday, July 30th. The company reported $0.52 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.03). The business had revenue of $4.88 billion during the quarter, compared to analyst estimates of $4.78 billion. Fresenius Medical Care AG & Co. had a return on equity of 10.18% and a net margin of 7.34%. On average, sell-side analysts predict that Fresenius Medical Care AG & Co. will post 2.38 earnings per share for the current fiscal year.

Several equities research analysts have weighed in on FMS shares. Zacks Investment Research downgraded Fresenius Medical Care AG & Co. from a “hold” rating to a “sell” rating and set a $41.00 price target for the company. in a report on Monday, July 1st. Royal Bank of Canada reissued a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a report on Monday, August 19th. JPMorgan Chase & Co. reissued a “buy” rating on shares of Fresenius Medical Care AG & Co. in a report on Thursday, August 29th. ValuEngine raised Fresenius Medical Care AG & Co. from a “sell” rating to a “hold” rating in a report on Wednesday, October 2nd. Finally, DZ Bank reissued a “neutral” rating on shares of Fresenius Medical Care AG & Co. in a report on Tuesday, July 30th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and four have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $53.05.

Fresenius Medical Care AG & Co. Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

Featured Article: How are Outstanding Shares Different from Authorized Shares?

Institutional Ownership by Quarter for Fresenius Medical Care AG & Co. (NYSE:FMS)

Receive News & Ratings for Fresenius Medical Care AG & Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius Medical Care AG & Co. and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


 
© 2006-2019 BBNS.